SCHEMBL2372258

SCHEMBL2372258

O=S(=O)(NC1CC1)c1ccc(Cl)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.57
ALDH1A1 P00352 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
DRD2 P14416 1/20 0.52
ADRA1D P25100 1/20 0.52
ADRA1A P35348 1/20 0.52
ADRA1B P35368 1/20 0.52
CNR2 P34972 2/20 0.50
CNR1 P21554 1/20 0.50
ITGA1 P56199 4/20 0.47
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MCOLN3 Q8TDD5 1/20 0.46
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ALOX12 P18054 1/20 0.44
NLRP1 Q9C000 1/20 0.44
KDM4E B2RXH2 1/20 0.44
EDNRA P25101 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735785 0.89 HDAC8 (0.52) HDAC8ALDH1A1L3MBTL1DRD2ADRA1D
SCHEMBL22315136 0.83 ALDH1A1 (0.54) HDAC8ALDH1A1L3MBTL1DRD2ADRA1D
SCHEMBL24667090 0.83 DRD2 (0.53) HDAC8ALDH1A1L3MBTL1DRD2ADRA1D
SCHEMBL4737973 0.83 HDAC8 (0.53) HDAC8ALDH1A1L3MBTL1DRD2ADRA1D
SCHEMBL3528220 0.80 HDAC8 (0.52) HDAC8ALDH1A1L3MBTL1CNR2ITGA1
SCHEMBL3524852 0.80 HDAC8 (0.46) HDAC8ALDH1A1L3MBTL1CNR2CNR1
SCHEMBL6867708 0.79 KMT5B (0.63) HDAC8ALDH1A1L3MBTL1KMT2ATDP1
SCHEMBL6867709 0.79 KMT5B (0.63) HDAC8ALDH1A1L3MBTL1KMT2ATDP1
SCHEMBL4030282 0.79 ALDH1A1 (0.87) ALDH1A1L3MBTL1CNR2CNR1KMT2A
SCHEMBL4734558 0.78 STS (0.57) HDAC8ALDH1A1L3MBTL1DRD2ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP claimed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US claimed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO claimed
EP-2547204-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS Bayer Intellectual Property GmbH (DE) 2013-01-23 EP disclosed
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 US disclosed
WO-2011113861-A2 ARYL AND HETARYL SULFONAMIDES AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS BAYER CROPSCIENCE AG (DE) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230350-A1 ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS STS, ARSA, TST HDAC8 879/4885ALDH1A1 1980/4885L3MBTL1 3916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.